Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 4 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.


Player Avatar Momentum21 (44.33) Submitted: 5/19/2011 1:59:18 PM : Outperform Start Price: $1.86 THLD Score: +186.56

Looking for a bounce into ASCO. We are past yet another round of dilution and there has been some notable insider and institutional buying of late. Highly speculative but not much more then some of my other holdings. M21 in at yah

Report this Post 11 Replies
Member Avatar Momentum21 (44.33) Submitted: 2/3/2012 12:57:24 PM
Recs: 1

took awhile but boo YAH!

Member Avatar portefeuille (99.66) Submitted: 2/21/2012 10:36:22 AM
Recs: 0


Member Avatar Momentum21 (44.33) Submitted: 2/21/2012 10:46:34 AM
Recs: 0

sometimes you just got to let it run... : )

Member Avatar Momentum21 (44.33) Submitted: 2/21/2012 10:55:48 AM
Recs: 0

Porte: yeay is right...DSCO is next on tap...and that is where the real chips are placed! : )

THLD @ 6.34 ... DSCO now @ 2.82

Member Avatar Momentum21 (44.33) Submitted: 2/21/2012 11:08:31 AM
Recs: 0

Porte: next up DSCO?

Member Avatar portefeuille (99.66) Submitted: 2/23/2012 12:25:38 PM
Recs: 0


Member Avatar portefeuille (99.66) Submitted: 2/23/2012 12:27:47 PM
Recs: 0

Member Avatar Momentum21 (44.33) Submitted: 3/14/2012 10:55:40 AM
Recs: 0

this stock makes me smile... : )

This was one of the most random of my picks and at the time I had thought my timing was terrible. It was a small initial position that is now one of my largest dollar gainers.

From here I like DSCO, SNSS and HGSI to follow suit in the short term. : )

What are your top 3 Portefeuille? I know DSCO is #1 of course

Member Avatar Momentum21 (44.33) Submitted: 10/1/2012 2:35:24 PM
Recs: 1

I bought back a bunch of shares at $5.97 (doubled the existing position) after the fallout from the weekend (ESMO). Nate Sadeghi and Adam F are I upped my bullishness. : )

Member Avatar portefeuille (99.66) Submitted: 10/3/2012 1:31:15 AM
Recs: 0

fund's top3 single company positions are ALGETA:NO, MOR:GY and ROG:VX currently.
Including IBB and BB Biotech (BION:SW) holdings the fund's top4 positions are probably ALGETA:NO, CELG, GILD and VRTX. That depends on current holdings of BB Biotech ->

Member Avatar portefeuille (99.66) Submitted: 10/3/2012 1:38:31 AM
Recs: 0

Maybe Actelion makes the top4, I just hope they have scaled back that position since the end of June. I keep adjusting the BION:SW position size a little depending on the discount to NAV, see and
I hope Vontobel makes another offer to acquire them in the not so distant future ->

Featured Broker Partners